3 ms·
That 94% was against symptoms, not infection. They didn't measure infection, so there was no way to distinguish between stopping infection and still being infe
by Izkata 5y ago
That 94% was against symptoms, not infection. They didn't measure infection, so there was no way to distinguish between stopping infection and still being infected but stopping symptoms (and so still being able to spread it). Turns out, even before Omicron, it was mostly the second case.
- rhino369 5y agoCDC said 90% for asymptomatic infection once they did measure infection. https://www.aha.org/news/headline/2021-03-29-cdc-authorized-mrna-vaccines-effective-against-asymptomatic-infection https://www.aha.org/news/headline/2021-03-29-cdc-authorized-... The change is partly that the effectiveness wanes after a few months and partly that its less effectively again new variants like Delta and Omicron. You can create delta+omicron mRNA vaccines to deal the second problem, but the first problem is much harder--and maybe impossible--to deal with. This is why we had low cases during the summer of 2021. The vaccine mostly worked at stopping the spread. It no longer does.